Skip to content

Evaluation of the relationship between maximal aerobic capacity and metabolic flexibility in response to fasting glucose/insulin in humans (Evaluación de la relación entre la capacidad aeróbica máxima y flexibilidad metabólica en respuesta a ayuno prolongado e infusión de glucosa/insulina en humanos)

Evaluation of the relationship between maximal aerobic capacity and metabolic flexibility in response to fasting glucose/insulin in humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN88318437
Enrollment
20
Registered
2017-10-31
Start date
2017-09-12
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic flexibility and maximal aerobic capacity in healthy subjects Nutritional, Metabolic, Endocrine

Interventions

In the selected individuals, the maximum aerobic capacity (by indirect calorimetry) and lactate threshold (by concentration in lactate venous blood) in an exercise bicycle will be determined. On a sec

Sponsors

Fondecyt
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Healthy men (by physical examination, past and current medical history, and routine blood testing, including biochemical profile, thyroid-stimulating hormone, free thyroxine, electrolytes, creatinine, and hemogram) 2. Between 18 and 35 years old 3. IMC: 18.5 – 25 kg/m2 4. Stable body weight (change<2 kg over the past 3 months) 5. Physical activity (<3 days/week) 6. Do not take medications

Exclusion criteria

Exclusion criteria: 1. Men with any disease 2. Younger than 18 years old and older than 35 years old 3. Unstable weight (change>2 kg over the past 3 months) 4. Physical activity (>3 days/wk) 5. Taking medications

Design outcomes

Primary

MeasureTime frame
1. Resting metabolic rate and respiratory quotient, measured by indirect calorimetry at two of three sessions with an interval of 4-7 days during the month following the selection 2. Glucose metabolic flexibility, measured by euglycemic-hyperinsulinemic clamp 3. Maximal aerobic capacity, measured by indirect calorimetry and a blood sample for lactate concentration in venous blood during exercise for 15 minutes. This measurement is performed during the month following the selection

Secondary

MeasureTime frame
1. Glucose, lactate, free fatty acids, triglycerides, VLDL, 3-OH-butyrate and insulin concentration, measured by taking two blood samples with a 10-minute interval before and after the clamp 2. Body mass and body composition, measured using the body mass index formula (BMI) and electrical bioimpedance

Countries

Chile

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026